/Companies

Nerai

1 known investors

Find your way into Nerai

Sign up to find every way you can get introduced to Nerai

  • Your email: who you already know at Nerai, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nerai team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.

Investors · 1

Frequently asked questions

What does Nerai do?
Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
Who are Nerai's investors?
Nerai's investors include Kickfund.